Policy decisions on COVID-19 interventions should be informed by a local, regional and
national understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Introduction We estimated unit costs for COVID-19 case management for patients with
asymptomatic, mild-to-moderate, severe and critical COVID-19 disease in Kenya. Methods We …

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …

Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions
about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood …

Background Few studies have assessed the seroprevalence of antibodies against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCWs) …

Background A few studies have assessed the epidemiological impact and the cost-effectiveness
of COVID-19 vaccines in settings where most of the population had been exposed to …

Introduction The high proportion of SARS-CoV-2 infections that have remained undetected
presents a challenge to tracking the progress of the pandemic and estimating the extent of …

Policymakers in Africa need robust estimates of the current and future spread of SARS-CoV-2.
We used national surveillance PCR test, serological survey and mobility data to develop …

Background: Detailed understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
regional transmission networks within sub-Saharan Africa is key for guiding …

Background We sought to estimate SARS‐CoV‐2 antibody seroprevalence within representative
samples of the Kenyan population during the third year of the COVID‐19 pandemic and …